Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Histiocytosis
Jean‐François Emile, F. Cohen Aubart, Matthew Collin, et al.
The Lancet (2021) Vol. 398, Iss. 10295, pp. 157-170
Open Access | Times Cited: 89

Showing 1-25 of 89 citing articles:

The 5th edition of the World Health Organization Classification of Haematolymphoid Tumours: Myeloid and Histiocytic/Dendritic Neoplasms
Joseph D. Khoury, Éric Solary, Oussama Abla, et al.
Leukemia (2022) Vol. 36, Iss. 7, pp. 1703-1719
Open Access | Times Cited: 2535
The International Consensus Classification of Mature Lymphoid Neoplasms: a report from the Clinical Advisory Committee
Elı́as Campo, Elaine S. Jaffe, James R. Cook, et al.
Blood (2022) Vol. 140, Iss. 11, pp. 1229-1253
Open Access | Times Cited: 954
ALK-positive histiocytosis: a new clinicopathologic spectrum highlighting neurologic involvement and responses to ALK inhibition
Paul G. Kemps, Jennifer Picarsic, Benjamin H. Durham, et al.
Blood (2021) Vol. 139, Iss. 2, pp. 256-280
Open Access | Times Cited: 103
Molecular and clinicopathologic characterization of pediatric histiocytoses
Zofia Hélias‐Rodzewicz, Jean Donadieu, Nathalie Terrones, et al.
American Journal of Hematology (2023) Vol. 98, Iss. 7, pp. 1058-1069
Open Access | Times Cited: 28
Imaging in Erdheim-Chester Disease
Yashant Aswani, Aditi Patel, Xin Zhan, et al.
Radiographics (2024) Vol. 44, Iss. 9
Closed Access | Times Cited: 8
Clinical features and prognostic factors of pediatric Langerhans cell histiocytosis: a single-center retrospective study
Yunfeng Lu, Liying Liu, Qi Wang, et al.
Frontiers in Medicine (2025) Vol. 11
Open Access | Times Cited: 1
Langerhans Cell Histiocytosis and Other Histiocytic Lesions
R. Anne McKinney, Guanghua Wang
Head and Neck Pathology (2025) Vol. 19, Iss. 1
Open Access | Times Cited: 1
Incidence, prevalence and survival in patients with Langerhans cell histiocytosis: A national registry study from England, 2013–2019
Hanhua Liu, Charles Stiller, Colin Crooks, et al.
British Journal of Haematology (2022) Vol. 199, Iss. 5, pp. 728-738
Open Access | Times Cited: 28
Molecular Mutations in Histiocytosis: A Comprehensive Survey of Genetic Alterations
Padmini Pai, Arnav Nirmal, Lian Mathias, et al.
Molecular Biotechnology (2024)
Open Access | Times Cited: 6
Pathologic characteristics of histiocytic and dendritic cell neoplasms
Sun Och Yoon
Blood Research (2024) Vol. 59, Iss. 1
Open Access | Times Cited: 5
Long-term outcome and prognosis of mixed histiocytosis (Erdheim-Chester disease and Langerhans Cell Histiocytosis)
Francesco Pegoraro, Matthias Papo, F. Cohen Aubart, et al.
EClinicalMedicine (2024) Vol. 73, pp. 102658-102658
Open Access | Times Cited: 5
Cutaneous histiocytoses in children
S. Fraitag, Jean‐François Emile
Histopathology (2021) Vol. 80, Iss. 1, pp. 196-215
Closed Access | Times Cited: 28
Immunopathology of Tumefactive Demyelinating Lesions-From Idiopathic to Drug-Related Cases
Aigli G. Vakrakou, Maria-Evgenia Brinia, Ioanna Svolaki, et al.
Frontiers in Neurology (2022) Vol. 13
Open Access | Times Cited: 19
Anaplastic Lymphoma Kinase (ALK) in Posterior Cranial Fossa Tumors: A Scoping Review of Diagnostic, Prognostic, and Therapeutic Perspectives
Danai-Priskila V. Mousa, Georgios Mavrovounis, Dionysios Argyropoulos, et al.
Cancers (2024) Vol. 16, Iss. 3, pp. 650-650
Open Access | Times Cited: 4
Case report: Primary subcutaneous Rosai-Dorfman-Destombes of the scalp with intra-cranial involvement: diagnosis and treatment of a rare case with literature review
Qin Zhenwei, Tang Beiyan, Ding Chen, et al.
Frontiers in Neurology (2025) Vol. 16
Open Access
When flames hit the brain, and the spark is far away: the role of PET-CT in diagnosing neurological Erdheim-Chester disease
Caio César Diniz Disserol, Guilherme Fleury Perini, Flávia Fernandes Silva Zacchi, et al.
Arquivos de Neuro-Psiquiatria (2025) Vol. 83, Iss. 01, pp. 001-005
Open Access
IgG4-related disease and other fibro-inflammatory conditions
Francesco Peyronel, Emanuel Della‐Torre, Federica Maritati, et al.
Nature Reviews Rheumatology (2025)
Closed Access
Histiocytoses and reactive proliferations of histiocytes: current state of the art and evolving concepts—a report from the joint CSHP-EA4HP-SH workshop 2024, Hefei, China
Falko Fend, Stefan Dirnhofer, Caoimhe Egan, et al.
Virchows Archiv (2025)
Open Access
NTRK1 Gene Fusions Are Frequent in Juvenile Xanthogranuloma
Ernst Schlögl, Helga Hürner-Unterberger, Ingrid Simonitsch‐Klupp, et al.
The American Journal of Surgical Pathology (2025)
Closed Access
The 2020 World Health Organization classification of bone tumors: what radiologists should know
Sinchun Hwang, Meera Hameed, Mark J. Kransdorf
Skeletal Radiology (2022) Vol. 52, Iss. 3, pp. 329-348
Closed Access | Times Cited: 17
Advances in Understanding and Management of Erdheim-Chester Disease
Aniruddha Murahar Kulkarni, Prasanna Kumar Reddy Gayam, Jesil Mathew Aranjani
Life Sciences (2024) Vol. 348, pp. 122692-122692
Open Access | Times Cited: 3
BRAFV600E induces key features of LCH in iPSCs with cell type-specific phenotypes and drug responses
Giulio Abagnale, Raphaela Schwentner, Philipp Ben Soussia-Weiss, et al.
Blood (2024) Vol. 145, Iss. 8, pp. 850-865
Open Access | Times Cited: 3
Prevalence, patterns and outcomes of cardiac involvement in Erdheim–Chester disease
Lévi-Dan Azoulay, Marine Bravetti, F. Cohen Aubart, et al.
European Heart Journal (2022) Vol. 44, Iss. 26, pp. 2376-2385
Open Access | Times Cited: 14
B-cell lineage neoplasms transdifferentiating into histiocytic/dendritic cell neoplasms: diversity, differentiation lineage, genomic alterations, and therapy: Report from the 2021 SH/EAHP Workshop
Wenbin Xiao, Catalina Amador, James R. Cook, et al.
American Journal of Clinical Pathology (2023) Vol. 159, Iss. 6, pp. 522-537
Open Access | Times Cited: 7
Loss of function of ENT3 drives histiocytosis and inflammation through TLR-MAPK signaling
Ruth Shiloh, Ruth Lubin, Odeya David, et al.
Blood (2023) Vol. 142, Iss. 20, pp. 1740-1751
Closed Access | Times Cited: 7
Page 1 - Next Page

Scroll to top